FDA approval summary: vorinostat for treatment of advanced primary cutaneous T-cell lymphoma by Mann Bhupinder S, Johnson John R, Cohen Martin H, Justice Robert, Pazdur Richard in The oncologist (2007).

[PMID: 17962618] PubMed

Abstract

Discussed In Paper

Loading...

Dosing Information

No dosing information annotated.